Methadone's Rules Got Looser. Too Many Clinics Haven't Let Go.

Dustin Mets runs CompDrug, a behavioral health clinic in Columbus, Ohio, and this year he watched a number move that the old rules would have made almost impossible: three-month treatment retention among his patients on methadone rose 17 percent, largely because the clinic started sending people home with more medication and stopped treating a counseling appointment as the toll a patient had to pay for their dose, according to reporting from STAT News.

Federal regulators loosened methadone’s rules two years ago, and the culture inside too many clinics still hasn’t caught up.

Here is what that sentence means in practice. “Take-home methadone” is the bottle a patient gets to carry out the clinic door and dose with at home, instead of drinking it in front of a nurse every single morning — the difference between a treatment that fits around a job and kids, and one that requires showing up to a specific building, in a specific window, seven days a week, indefinitely. “Mandatory counseling,” under the old regime, meant a clinic could withhold your dose or strip your take-home privileges if you missed a therapy session, whether or not therapy was what you needed that week. Those two levers — how much medicine you got to leave with, and whether talk therapy was a condition of getting any medicine at all — were tightened by federal regulators after methadone maintenance began in the 1960s and stayed rigid for half a century. In February 2024, SAMHSA finalized a rewrite of the rule that governs them, 42 CFR Part 8 — the first overhaul of opioid treatment program regulations in more than two decades.

The new federal rule replaced a vague, clinician-judgment-driven “stable” versus “less stable” patient sorting system with a schedule tied to time in treatment: a patient can get up to seven days of take-home doses within their first two weeks, up to fourteen days between two weeks and a month, and up to a full 28-day supply after 31 days. Counseling is now something a program has to offer, not something it can hold a patient’s medicine hostage over. If you’ve been on methadone long enough to remember proving yourself for months with clean urine screens and perfect attendance before anyone handed you more than a single day’s dose at a time, that regime was not your imagination — it was federal policy, and as of two years ago, it is no longer what the law requires of your clinic.

A rule with roots in punishment, not medicine

Methadone has never been regulated like an ordinary medicine. When Dr. Beny Primm, a pioneering Black physician, tried to open a clinic in Harlem in the 1970s, opponents did more than object at zoning meetings — the building he was renovating was set on fire, and dogs he’d brought to guard the site were killed. Fights like that one, repeated for decades in cities from New York to Chicago, pushed clinics into carceral compromises: locked dosing windows, security cameras, signs threatening “involuntary withdrawal” for anyone caught lingering outside. By 1975, opening a new methadone program in New York City had become nearly impossible. The federal rules that followed encoded that same suspicion — patients as risks to be managed, not people to be trusted — and much of that architecture survived, largely unchanged, until 2024.

That history is why the STAT reporting matters: it is not a story about whether the rule changed. It changed. It is a story about whether the people running clinics, and the state regulators who oversee them, have let go of the reflex the old rule trained into them.

The gap between the memo and the front desk

Mark Parrino, president of the American Association for the Treatment of Opioid Dependence, points to real movement: in a survey of 241 opioid treatment programs — roughly one in ten nationwide — more than 75 percent reported providing more take-home medication, over 70 percent had adopted at least half of the flexibilities the new rule allows, and about two-thirds of state opioid treatment authorities had signed off on the counseling changes. Mets, at CompDrug, frames the shift in plain terms: “physical presence is a rather poor proxy for a strong therapeutic relationship,” he told STAT — a clinic doesn’t need a patient standing in a dosing line to know they’re doing well.

Aaron Ferguson, a longtime leader of the patient-advocacy Liberate Methadone movement, sees a different picture from the ground. “Most of the larger providers have not been proactive whatsoever with implementing those changes,” he told STAT, calling the industry’s self-reported progress “a misrepresentation.” Ferguson’s critique isn’t just rhetorical: the survey Parrino cites likely oversamples clinics confident enough in their own reform to respond, and it says nothing about the geographic split between states like New York, which pushed providers toward the new flexibilities, and more conservative states where old habits, and often the state regulators layered on top of the federal floor, haven’t moved. A federal rule sets what a clinic is now permitted to do — it does not force any state authority or clinic director to use the full flexibility it grants.

Aaron Ferguson, a longtime leader of the patient-advocacy Liberate Methadone movement, sees a different picture from the ground.

If you’re on methadone right now and your clinic is still making you show up daily, still treating a missed counseling appointment like a disciplinary infraction, you are not imagining a gap between what you’ve heard the rules allow and what your dosing window still requires of you. That gap is real, it is documented, and it is not evidence that the reform failed — it is evidence that a clinic or a state regulator is choosing not to use authority it already has.

Why the flexibility itself is not a technicality

The stakes of that gap are not abstract. A study out of the University of Colorado Anschutz Medical Campus, tracking 519 hospital visits across Connecticut, Maryland, and Colorado, found that 44 percent of patients sent home from the hospital with take-home methadone in hand successfully connected to an ongoing opioid treatment program within 72 hours — engagement rates that climbed further for patients discharged to structured care or given higher doses. Lead author Dr. Susan Calcarra put the window in stark terms: “this is a moment where a life can tip one way or the other. And we now have a practical, economical, and proven way to help people stay on the path to recovery.” Take-home flexibility isn’t a convenience feature bolted onto methadone treatment — in the days right after a hospital discharge, it can be the difference between a person staying connected to care and falling through the gap between the ER and the next available clinic appointment.

None of this is settled science waiting to be tested. It’s federal law, already in effect, that a person on methadone can hold their clinic to today — even in a state or a program that hasn’t finished catching up.

The rule changed in Washington first, because it always does. The next fight over methadone won’t be fought in the Federal Register — it’ll be fought clinic by clinic, at the front desk, the first time a patient asks for the 28-day bottle the law already says they’re owed.